Clinical Trial Update: A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating intravenous denileukin diftitox in stage III/IV ovarian cancer (epithelial ovarian cancer, extraovarian peritoneal cancer, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Extraovarian Peritoneal Cancer
• Fallopian Tube Carcinoma

Drugs mentioned

• ONTAK (denileukin diftitox)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-10-19